VIBE: Evaluation of Ibandronate Efficacy - Original Investigation

by J-Y Reginster, S Poston
Published 2008-12-01

VIBE: Evaluation of Ibandronate Efficacy - Original Investigation

by J-Y Reginster, S Poston
Published 2008-12-01

STRONTIUM RANELATE DEMONSTRATES VERTEBRAL AND NON-VERTEBRAL ANTI FRACTURE EFFICACY INCLUDING HIP FRACTURES OVER 5 YEARS IN POST MENOPAUSAL OSTEOPOROTIC WOMEN

by J Y REGINSTER, K BRIXEN, C CORMIER, J CANNATA
Published 2007-08-01

KAL'TsIY I VITAMIN D V VEDENIIOSTEOPOROZA

by R RIZZOLI, S BOONEN, M L BRANDI, P DELMAS, J Y REGINSTER
Published 2007-08-01

STRONTIUM RANELATE DECREASES VERTEBRAL FRACTURE RISK WHATEVER THE LEVEL OF PRETREATMENT BONE TURNOVER MARKERS

by J COLLETTE, J Y REGINSTER, O BRUYÈRE, C ROUX, R LORENC, D FELSENBERG, T D SPECTOR
Published 2007-08-01

Identifying maternal needs following childbirth: A qualitative study among mothers, fathers and professionals

by J. Slomian, P. Emonts, L. Vigneron, A. Acconcia, F. Glowacz, J. Y. Reginster, M. Oumourgh, O. Bruyère
Published 2017-07-01

Long treatment with strontium ranelate of womenwith postmenopausal osteoporosis: 10-year results

by J Y Reginster, J M Kaufman, S Goemaere, C L Benhamou, A Balogh, C Albanese, J Badurski, C Roux
Published 2011-04-01

Loading and Skeletal Development and Maintenance

by P. Bergmann, J. J. Body, S. Boonen, Y. Boutsen, J. P. Devogelaer, S. Goemaere, J. Kaufman, J. Y. Reginster, S. Rozenberg
Published 2011-01-01

Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications

by J.-J. Body, P. Bergmann, S. Boonen, J.-P. Devogelaer, E. Gielen, S. Goemaere, J.-M. Kaufman, S. Rozenberg, J.-Y. Reginster
Published 2013-02-01

Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications

by J.-J. Body, P. Bergmann, S. Boonen, J.-P. Devogelaer, E. Gielen, S. Goemaere, J.-M. Kaufman, S. Rozenberg, J.-Y. Reginster
Published 2013-04-01

Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial

by Cyrus Cooper, J-Y Reginster, R Chapurlat, C Christiansen, H Genant, N Bellamy, W Bensen, F Navarro, J Badurski, E Nasonov, X Chevalier, P N Sambrook
Published 2013-12-01

Five-year denosumab treatment of postmenopausalwomen with osteoporosis: results of the first twoyears of the freedom trial extension.

by S Papapoulos, Z Man, D Mellstrom, S Radominski, J-Y Reginster, H Resch, J Roman, S Roux, S Cummings, H Bone, R Chapurlar, M Brandi, J Brown, E Czerwinski, N Daizadeh, A Grauer, M-A Krieg, S Libanati
Published 2011-04-01